• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Biol Evol . Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection

tetano

Editor, Senior Moderator
Mol Biol Evol


. 2022 May 3;msac091.
doi: 10.1093/molbev/msac091. Online ahead of print.
Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection


Christopher Markosian[SUP] 1 2 [/SUP], Daniela I Staquicini[SUP] 1 2 [/SUP], Prashant Dogra[SUP] 3 4 [/SUP], Esteban Dodero-Rojas[SUP] 5 [/SUP], Joseph H Lubin[SUP] 6 [/SUP], Fenny H F Tang[SUP] 1 2 [/SUP], Tracey L Smith[SUP] 1 2 [/SUP], Vinícius G Contessoto[SUP] 5 [/SUP], Steven K Libutti[SUP] 7 8 [/SUP], Zhihui Wang[SUP] 3 4 [/SUP], Vittorio Cristini[SUP] 3 9 10 11 [/SUP], Sagar D Khare[SUP] 6 7 12 [/SUP], Paul C Whitford[SUP] 13 [/SUP], Stephen K Burley[SUP] 6 7 12 14 15 [/SUP], José N Onuchic[SUP] 5 16 17 18 [/SUP], Renata Pasqualini[SUP] 1 2 19 [/SUP], Wadih Arap[SUP] 1 20 19 [/SUP]



Affiliations

Abstract

Evaluation of immunogenic epitopes for universal vaccine development in the face of ongoing SARS-CoV-2 evolution remains a challenge. Herein, we investigate the genetic and structural conservation of an immunogenically relevant epitope (C662-C671) of spike (S) protein across SARS-CoV-2 variants to determine its potential utility as a broad-spectrum vaccine candidate against coronavirus diseases. Comparative sequence analysis, structural assessment, and molecular dynamics simulations of C662-C671 epitope were performed. Mathematical tools were employed to determine its mutational cost. We found that the amino acid sequence of C662-C671 epitope is entirely conserved across the observed major variants of SARS-CoV-2 in addition to SARS-CoV. Its conformation and accessibility are predicted to be conserved, even in the highly mutated Omicron variant. Costly mutational rate in the context of energy expenditure in genome replication and translation can explain this strict conservation. These observations may herald an approach to developing vaccine candidates for universal protection against emergent variants of coronavirus.

Keywords: COVID-19; epitope; variants.
 
Back
Top Bottom